DBEQ

CAS No. 177355-84-9

DBEQ ( N,N'-Dibenzylquinazoline-2,4-diamine; JRF 12 )

Catalog No. M12670 CAS No. 177355-84-9

DBeQ(JRF-12) is a selective, potent, reversible, and ATP-competitive p97 inhibitor with IC50 of 1.5 μM.

Purity : >98%(HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 48 In Stock
10MG 86 In Stock
25MG 171 In Stock
50MG 308 In Stock
100MG 389 In Stock
200MG 575 In Stock
500MG 888 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    DBEQ
  • Note
    Research use only, not for human use.
  • Brief Description
    DBeQ(JRF-12) is a selective, potent, reversible, and ATP-competitive p97 inhibitor with IC50 of 1.5 μM.
  • Description
    DBeQ(JRF-12) is a selective, potent, reversible, and ATP-competitive p97 inhibitor with IC50 of 1.5 μM.
  • Synonyms
    N,N'-Dibenzylquinazoline-2,4-diamine; JRF 12
  • Pathway
    Proteasome/Ubiquitin
  • Target
    p97
  • Recptor
    p97
  • Research Area
    Cancer
  • Indication
    ——

Chemical Information

  • CAS Number
    177355-84-9
  • Formula Weight
    340.42
  • Molecular Formula
    C22H20N4
  • Purity
    >98%(HPLC)
  • Solubility
    Ethanol: 5 mg/mL (14.68 mM); DMSO: 68 mg/mL (199.75 mM)
  • SMILES
    C12=CC=CC=C1N=C(NCC3=CC=CC=C3)N=C2NCC4=CC=CC=C4
  • Chemical Name
    N2,N4-dibenzylquinazoline-2,4-diamine

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Chou TF, et al. Proc Natl Acad Sci U S A, 2011, 108(12), 4834-4839.
molnova catalog
related products
  • UPCDC30245

    UPCDC30245 is an allosteric inhibitor of AAA ATPase p97 with IC50 of 27 nM.

  • MSC 1094308

    MSC1094308 (MSC 1094308) is a reversible, allosteric inhibitor of the type II AAA ATPase human ubiquitin-directed unfoldase (VCP)/p97 and the type I AAA ATPase VPS4B with IC50 of 7.2 and 0.71 uM, respectively.

  • CB-5083

    CB-5083 is a potent, selective, orally bioavailable inhibitor of p97 AAA with IC50 of 11 nM.